Biobizkaia
Research center
Universidade Federal de Minas Gerais
Belo Horizonte, BrasilPublications in collaboration with researchers from Universidade Federal de Minas Gerais (19)
2024
-
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study
Brain, Vol. 147, Núm. 8, pp. 2652-2667
2023
-
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034
2022
-
Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)
Infection
-
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry
Infection, Vol. 50, Núm. 5, pp. 1191-1202
2021
2020
-
Standardization of Nomenclature for Ocular Tuberculosis–Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop
Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 74-84
-
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings
Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 85-95
-
The Iberian legacy into a young genetic xeroderma pigmentosum cluster in central Brazil
Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 852
2017
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
2016
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2004
-
Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse
Journal of Neuroscience, Vol. 24, Núm. 26, pp. 5955-5965
2003
-
Possible involvement of a fibroblast growth factor 9 (FGF9)-FGF receptor-3-mediated pathway in adult pig retinal ganglion cell survival in vitro
Molecular and Cellular Neuroscience, Vol. 23, Núm. 1, pp. 39-53